Press Release
NEW YORK--(BUSINESS WIRE)--Ataraxis AI, a frontier clinical artificial intelligence (AI) company developing AI-powered tools for oncology, today announced that its laboratory has received accreditation from the College of American...
August 25, 2026 - Stratipath, a leader in AI-based precision diagnostics for breast cancer, and Aiforia, a pioneer in AI-driven diagnostics in pathology, today announced a strategic partnership. This collaboration aims to provide pathologists...
Bioptimus to use Cancer Research Horizons’ data to train and evaluate its AI foundation model Third partnership since Bioptimus launched ground-breaking STELA initiative in March Deal adds Bioptimus' first UK patient cohort to...
Imagene AI: Integration with Proscia’s Concentriq platform will facilitate pharma companies, diagnostic assay and platform providers, and CROs in operationalizing companion diagnostic programs August 18, 2026 Imagene AI, a leader in...
Lumea: Company Recognized for Large Revenue Growth, Earning a Place Among the Nation’s Most Successful Independent Businesses LEHI, UT, UNITED STATES, August 11, 2026 /EINPresswire/ — Lumea today announced it has been ranked No. 1,641 on...
aetherAI: Delivering Integrated Software-and-Hardware Consulting Solutions for the Global Digital Transformation of Pathology — Growth Momentum Poised to Accelerate aetherAI (7803), a global leader in digital pathology and AI healthcare...
